Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
May 10 10:55AM ET
31.12
Dollar change
-0.04
Percentage change
-0.14
%
CategoryGlobal or ExUS Equities - Industry Sector Asset TypeEquities (Stocks) TagsGlobal Return% 1Y4.06% Shs Outstand Perf Week0.57%
SponsorFranklin Templeton ETF Type Tagsequity Return% 3Y-9.90% Total Holdings66 Perf Month-2.37%
Fund Family Bond Type Tagshealthcare Return% 5Y- AUM9.35M Perf Quarter1.34%
Index- Average Maturity Tagsgenomics Return% 10Y NAV% Perf Half Y16.77%
Index Weighting Commodity Type Tags- Return% SI NAV/sh Perf Year3.39%
Active/Passive Quant Type Tags- Flows% 1M0.00% 52W Range25.26 - 32.92 Perf YTD2.13%
Dividend TTM- ESG Type Tags- Flows% 3M0.00% 52W High-5.47% Beta1.07
Dividend Ex-DateDec 30, 2021 Dividend Type Sector/Theme Flows% YTD-13.83% 52W Low23.20% ATR (14)0.32
Expense0.50% Structure Type Region Flows% 1Y RSI (14)52.15 Volatility0.19% 0.37%
Option/ShortYes / Yes Growth/Value Dev/Emerg Flows% 3Y Rel Volume0.04 Prev Close31.16
Inverse/Leveraged Market Cap Currency Flows% 5Y Avg Volume0.89K Price31.12
SMA202.10% SMA50-1.65% SMA2004.33% Trades Volume12 Change-0.14%
Jul-16-21 11:19AM
Jan-14-21 09:15AM
Oct-05-20 08:00AM
Franklin Genomic Advancements ETF seeks capital appreciation. Under normal market conditions, the fund invests at least 80% of its net assets in equity securities of companies that are relevant to its investment theme of genomic advancements. The fund invests predominantly in common stock. Although it may invest across economic sectors, the fund concentrates its investments in health care related industries. It is non-diversified.